Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellulitis optimal antibiotic treatment
ISRCTN27053187Phase 3Active, not recruiting
- Sponsor
- University of Southampton
- Start
- Aug 2023
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of flucloxacillin in cellulitis (2 arms), sponsored by University of Southampton. Primary endpoint: Self-reported pain. Started Aug 2023; status: active, not recruiting.
02
Drugs
flucloxacillin
03
Conditions
cellulitis
Beyond the preview
Go deeper on ISRCTN27053187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN27053187.